Agenda Sessions

Agenda Sessions

February 27, 2013

7:30 a.m. - Registration Opens

7:30 a.m. - 8:30 a.m.Breakfast & Networking

8:00 a.m. - 5:00 p.m.Partnering Open 1:1 Meetings

8:00 a.m. - 8:30 a.m.Welcome Remarks

8:30 a.m. - 9:45 a.m.Perspectives from Large Pharma

Moderator:
Susan Schaeffer, Editor, BioCentury, The Bernstein Report on BioBusiness

Panelists:
George S. Golumbeski, PhD, SVP BD,Celgene Corporation
Brian McVeigh, Vice President, WWBD Transactions and Investment Management, GlaxoSmithKline Pharmaceuticals
Tony Rosenberg, Head of Global BD & Licensing, Novartis
Barbara Yanni, Vice President and Chief Licensing Officer, Merck

9:45 a.m. - 10:00 a.m.Networking Break

10:00 a.m. - 10:30 a.m.Keynote: A Model for Team-Based Biomedical Research -- Reflections

John C. Reed, MD, Ph.D., Professor and Donald Bren Chief Executive Chair, Former Chief Executive Officer, Sanford-Burnham Medical Research Institute

10:30 a.m. - 11:45 a.m.Accessing Early Stage Innovation

Moderator:
John C. Reed, MD, Ph.D., Professor and Donald Bren Chief Executive Chair, Former Chief Executive Officer, Sanford-Burnham Medical Research Institute

Panelists:
Tom Bumol, Site Head at AME, Eli Lilly and Company
Adam Keeney, VP, Head of Transactions, Johnson & Johnson West Coast Innovation Centers
Rick Lindberg, Executive Director and Site Head, Centers for Therapeutic Innovation, California, Pfizer Inc.
Jim Schaeffer, Executive Director of Licensing & External Research, Merck Research Lab

11:45 a.m. - 12:30 p.m.Networking Lunch

12:30 p.m. - 1:00 p.m.Going Public in a Challenging Environment

Presenter:
Kleanthis Xanthopoulos, President and CEO, Regulus Therapeutics

1:00 p.m. - 2:00 p.m.Fireside Chat: Reflections on the Unexpected

Moderator:
Mark Wiggins, SVP Business Development, Elcelyx

Presenter:
Bill Rastetter, Chairman, Illumina; Chairman, Neurocrine Biosciences; Chairman, Fate Therapeutics; Chairman, Receptos, Inc.

2:10 p.m. - 5:10 p.m.Company Presentations

5:15 p.m. - 7:30 p.m.Gala Reception

February 28, 2013

7:30 a.m. - 8:30 a.m.Breakfast & Networking

8:00 a.m. - 3:30 p.m.Partnering Open 1:1 Meetings

8:30 a.m. - 9:45 a.m.Building a Successful New Company

Moderator:
Jennifer Giottonini Cayer, Chief Operating Officer, Rempex Pharmaceuticals, Inc.

Panelists:


Alain Baron, President & CEO, Director, Elcelyx
Dan Burgess, President & CEO, Rempex Pharmaceuticals
Kurt Graves, Chariman & CEO, Intarcia Therapeutics
Rich Heyman, CEO, Aragon Pharmaceuticals
Gonul Velicelebi, Founder, President and CEO, CalciMedica

9:45 a.m. - 10:00 a.m.Networking Break

10:00 a.m. - 12:20 p.m.Company Presentations

12:15 p.m. - 12:45 p.m.Networking Lunch

12:45 p.m. - 2:15 p.m.Trends in Business Development

Moderator:
Miranda Biven, Partner, Wilson Sonsini Goodrich & Rosati

Panelists:

Richard Brudnick, Vice President of Business Development, Biogen-Idec
Iain Dukes, Vice President, External Research and Development, Amgen
Ronald C. Newbold, Vice President - Strategic Research Partnerships, External R&D Innovation, Worldwide Research & Development, Pfizer, Inc.
Terence Porter, Vice President, Search & Evaluation, Global Business Development, Takeda Pharmaceuticals International, Inc.
Rob Wills, Vice President, Alliance Management, Johnson & Johnson

2:15 p.m. - 2:30 p.m.Networking Break

2:30 p.m. - 4:00 p.m.Venture Financing

Moderator:
Lewis Geffen, Co-Chair, VC and Emerging Companies Practice, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo

Panelists:
Corey Goodman, Partner, venBIO LLC
David Kabakoff, Executive Partner, Sofinnova
Michael Ross, Managing Partner, SV Life Sciences
James Topper, General Partner, Frazier Healthcare

4:00 p.m. - 5:15 p.m.Closing Reception